About instinct bio technical co holdings inc - BIOT
Instinct Bio Technical Co. Holdings, Inc. is an integrated regenerative medicine and longevity company focused on research, manufacturing, and commercialization of regenerative health technologies. It develops stem cell-derived products, wellness solutions, and advanced skincare products. The company was founded in 2017 is headquartered in Tokyo Japan.
BIOT At a Glance
Instinct Bio Technical Co. Holdings, Inc.
3F, West Side Gotanda Building
Tokyo, Tokyo 1410031
| Phone | 81-3-5747-7941 | Revenue | 0.00 | |
| Industry | Financial Conglomerates | Net Income | -1,225,143.00 | |
| Sector | Finance | Employees | 2 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
BIOT Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -51.867 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | 0.008 |
BIOT Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -612,571.50 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
BIOT Liquidity
| Current Ratio | 0.006 |
| Quick Ratio | 0.006 |
| Cash Ratio | 0.002 |
BIOT Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -151.621 |
| Return on Equity | N/A |
| Return on Total Capital | 45.986 |
| Return on Invested Capital | N/A |
BIOT Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | -16.26 |
| Total Debt to Total Assets | 53.315 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |